Aemetis AMTX 深 滬
已收盤 12-19 16:00:00 美东时间
1.48
+0.050
+3.50%
華盛通- 最 高1.49
- 今 開1.44
- 成交量 74.15万股
- 最 低 1.4303
- 昨 收 1.43
- 總市值 9359.67万
- 52周最高 3.66
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.22
- 委 比 -49.42%
- 總股本 6324.10万
- 歷史最高 27.44
- 量 比 0.94
- 振 幅 4.17%
- 歷史最低 0.152
- 每 手 1
- 風險率 0.53%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Shares of oil and gas companies are trading lower. The commodity may be falling in reaction to peace negotiations between Russia and Ukraine.
Shares of oil and gas companies are trading lower. The commodity may be falling...
12-16 01:05
Aemetis Receives Authority to Construct Air Permits for MVR Project at California Ethanol Plant
Aemetis has received permits for its mechanical vapor recompression (MVR) project at its Keyes ethanol plant, which is expected to boost annual cash flow by $32 million starting mid-2026. The project, funded by $19.7 million in grants, aims to reduce natural gas usage by 80%, lower carbon intensity, and increase tax credits. Completion is slated for Q2 2026, furthering Aemetis' decarbonization efforts and renewable fuel production in California.
12-02 13:00
美股大行评级 | 高盛上调百度、美敦力、晶科能源等多只个股目标价；家得宝遭9家机构下调目标价；
今日重点评级关注：富国银行：维持Annexon"超配"评级，目标价从14美元升至27美元；瑞穗：上调Relmada Therapeutics评级至"跑赢大市"，目标价从1美元升至10美元
11-20 10:28
Ascendiant Capital Maintains Buy on Aemetis, Lowers Price Target to $20
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $21 to $20.
11-19 18:28
Aemetis Q3 EPS $(0.37) Misses $(0.20) Estimate, Sales $59.190M Miss $87.035M Estimate
Aemetis (NASDAQ:AMTX) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.20) by 85 percent. This is a 2.63 percent increase over losses of $(0.38) per share from the same
11-06 20:58
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
Aemetis to Review Third Quarter 2025 Financial Results on November 6, 2025
Aemetis, Inc. (NASDAQ: AMTX) invites investors to a conference call on Thursday, November 6, 2025, at 11 am PT to discuss its third quarter 2025 earnings. Participants can join via toll-free or international dial-in numbers (entry code 188767) or via webcast at https://www.webcaster5.com/Webcast/Page/2211/53150. Questions will be addressed during the Q&A session. A voice recording will be available until November 13, and the webcast will remain a...
10-31 12:00
API reverses stance on bill to expand sales of E15 gasoline
The American Petroleum Institute said Tuesday it opposes legislation to expand year-round sales of E15 gasoline, marking a reversal for the prominent oil and gas trade group. The API said in a letter ...
10-22 08:48
Aemetis Extends Redemption Date for Preferred Units
An update from Aemetis ( ($AMTX) ) is now available. On October 15, 2025, Aemet...
10-22 05:29
Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit
Autonomix Medical, Inc. will participate in the 2025 Maxim Growth Summit on October 22-23 in New York. The event will feature in-person meetings with investors and showcase the company's innovative neural sensing technology for treating nervous system diseases, initially targeting pain management in conditions like pancreatic cancer. Maxim Group, a full-service financial firm, is organizing the summit. For more details, visit www.maximgrp.com/202...
10-16 13:15
